• Celerion Newsletter
Belfast - Center of Excellence for Respiratory

Celerion

committed to service excellence

Primary Navigation for Celerion

  • Home
  • About Celerion
    • Why Celerion?
    • Mission, Vision and Credo
    • Management Team
    • Who We Work With
    • Locations
    • Environmental Sustainability
  • Applied Translational Medicine
    • Key Elements of Success
  • Services
    • Global Clinical Research
      • AAHRPP Accreditation
      • Phase I and lla Studies
      • In-hospital Beds
      • Study Experience
      • Belfast – Center of Excellence for Respiratory
      • Early Cardiac Services
      • Hybrid Phase I/ECG Core Lab
      • ADME/Mass Balance
      • Microtracer Studies
      • USP <797> Clean Room
      • ClinQuick® Electronic Data Acquisition
      • Recruitment
    • Clinical Pharmacology Sciences
      • Modeling and Simulation
      • Study Design and Protocol Development
      • Data Programming
      • Biostatistics
      • Pharmacokinetics/Pharmacodynamics (PK/PD)
      • Medical Writing and Reporting
      • Streamlined Data Flow Process
    • Global Bioanalytical Services
      • Small Molecule
      • Large Molecule
      • Electronic Laboratory Notebook System
      • ADME/Mass Balance
    • Drug Development Services
      • Biopharmaceutical Development
      • Program and Project Management
      • Regulatory Affairs
  • Celerion Europe
    • Global Clinical Research
    • Clinical Pharmacology Sciences
    • Global Bioanalytical Services
    • Management Team
  • The Biosimilars Alliance
    • The Biosimilars Alliance – Overview
    • The Biosimilars Alliance – Benefits
  • Case Studies
    • Global Clinical Research
      • Responding to an Unexpectedly High Drop Rate
      • Mass Balance Study
      • Semen Clinical Trials
    • Clinical Pharmacology Sciences
      • Partnering with Biotechnology Companies
      • Partnering with Large Pharmaceutical Companies
      • Protocol Study Design and Development for Generic Studies
      • Difficult to Recruit Population
      • Consistent Database Structure for Programs of Studies
    • Global Bioanalytical Services
      • Improved Desmopressin Analysis of Clinical Samples
      • Optimized LC-MS/MS Method for New Observed Metabolite
      • Bioanalytical Support of Oncology Studies
      • High Throughput Bioanalytical Analysis
      • Partnering with Biotechnology Companies
      • Partnering with Pharmaceutical Companies
      • Development of an LC-MS/MS Peptide Method
    • Drug Development Services
      • Support of CMC to IND for Novel First-in-Class Small Molecule Drugs
      • Rapid Proof-of-Concept for Novel Drug Treatment for Rare Metabolic Disease
      • Proof-of-Concept Efficacy Clinical Study
      • European Biotechnology Company Seeking First-in-Human U.S. Clinical Study
      • Asian Biotechnology Company with CNS Compound
  • White Papers
  • Other Resources
  • News & Events
    • Press Room
    • Conferences
    • Symposia
    • Webinars
  • Participate in a Study
  • Careers
    • Message from the CEO
    • Culture
  • Spring 2013 Newsletter
  • Fall 2012 Newsletter
  • Spring 2012 Newsletter

Services > Global Bioanalytical Services

Electronic Laboratory Notebook System

Electronic laboratory notebook enables faster access to data and improved information quality due to centralized data repositories.

Real time data integrity eliminates manual calculations and sources of potential error.

Celerion customized and implemented Labnotes, a commercially available electronic laboratory notebook system to standardize bioanalytical processes and improve documentation consistency for all studies.

Consistent documentation for all studies

Benefit from faster access to data no matter where samples are analyzed.

Central data repositories support both local and global access so that individual scientists and production teams can review and approve bioanalytical study documentation as it is generated, eliminating needless delays.

Real-time data integrity eliminates manual calculations and sources of potential error

Benefit from improved data integrity and more confidence in all programs.

Electronic laboratory notebook builds in calculations for critical aspects of the bioanalytical workflow, standardizing everything from reference standard weighing to instrument and pipette calibration, increasing consistency and eliminating common sources of error. Instruments or materials that pass their calibration expiry date are flagged in the system so they will not be used without review.

Improved information quality

Benefit from built-in quality control throughout the bioanalytical workflow.

Real-time quality control provides a benefit to all studies throughout the bioanalytical workflow by ensuring quality data is delivered correctly the first time. The global team of scientists designed and implemented every secure form to optimize quality. All the documentation is legible and reliable, eliminating the need to query handwritten entries in notebooks or forms. Chromatographic columns, instruments, solutions and tools are all bar-coded and scanned into the system before use. Standardizing documentation frees scientists to design, organize, and share their methods and data along with securely protecting the analytical history of the project.

See also...

Validated Assay List: May 2013

Press Release: Celerion Electronic Laboratory Notebook

Webinar: Employing Real-Time Strategies in the Bioanalysis Workspace

Article: Challenges in archiving electronic bioanalytical data supporting GLP studies in a CRO

For more information contact us

Footer Naviation

  • About
  • Locations
  • Careers
  • Request a Proposal
  • Contact
  • Privacy Policy
© 2013 Celerion